102
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Is Echocardiography Mandatory for All Streptococcus gallolyticus Subsp. pasteurianus Bacteremia?

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 2425-2432 | Published online: 20 Jul 2020

References

  • Sharara AI, Abou Hamdan T, Malli A, et al. Association of Streptococcus bovis endocarditis and advanced colorectal neoplasia: a case-control study. J Dig Dis. 2013;14(7):382–387. doi:10.1111/1751-2980.1205923551389
  • L S, Collins MD, Re´gnault B, Grimont PA, Bouvet A. Streptococcus infantarius, Streptococcus infantarius subsp. infantarius and Streptococcus infantarius subsp. coli isolated from humans and food. Int J Syst Evol Microbiol. 2000;50:1425–1434. doi:10.1099/00207713-50-4-142510939646
  • Facklam RR. Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol. 1972;23:1131–1139. doi:10.1128/AEM.23.6.1131-1139.19724557563
  • Farrow JAE, Kruze J, Phillips BA, Bramley AJ, Collins MD. Taxonomic studies on Streptococcus bovis and Streptococcus equinus: description of Streptococcus galactolyticus and Streptococcus saccharolyticus. Syst Appl Microbiol. 1984;5:467–482. doi:10.1016/S0723-2020(84)80004-1
  • Osawa R, Fujisawa T, Sly LI. Streptococcus gallolyticus sp. gallate degrading organisms formerly assigned to Streptococcus bovis. Syst Appl Microbiol. 1995;18:74–78. doi:10.1016/S0723-2020(11)80451-0
  • Beck M, Frodl R, Funke G. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J Clin Microbiol. 2008;46:2966–2972. doi:10.1128/JCM.00078-0818614655
  • Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis. 2011;53(9):870–878. doi:10.1093/cid/cir60921960713
  • Lazarovitch T, Shango M, Levine M, Brusovansky R, Akins R, Hayakawa K. The relationship between the new taxonomy of Streptococcus bovis and its clonality to colon cancer, endocarditis, and biliary disease. Infection. 2013;41:329–337. doi:10.1007/s15010-012-0314-x22886774
  • Biarc J, Nguyen IS, Pini A, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis. 2004;25:1477–1484. doi:10.1093/carcin/bgh09114742316
  • Corredoira J, Alonso MP, García-Garrote F, et al. Streptococcus bovis group and biliary tract infections: an analysis of 51cases. Clin Microbiol Infect. 2014;20:405–409. doi:10.1111/1469-0691.1233324033711
  • McCoy WC. Enterococcal endocarditis associated with carcinoma of the sigmoid: report of a case. J Med Assoc State Ala. 1951;21:162–166.14880846
  • Nopjaroonsri P, Leelaporn A, Chayakulkeeree M Clinical characteristics of group D Streptococcal bacteremia in Siriraj Hospital. In: Proceedings of the 39th Thailand Infectious Disease Annual Conference Infectious Diseases Progress 2013; 2013; Chiang Mai, Thailand.
  • Romero B, Morosini MI, Loza E, et al. Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue. J Clin Microbiol. 2011;49(9):3228–3233. doi:10.1128/JCM.00524-1121752968
  • Sheng WH, Chuang YC, Teng LJ, Hsueh PR. Bacteraemia due to Streptococcus gallolyticus subspecies pasteurianus is associated with digestive tract malignancies and resistance to macrolides and clindamycin. J Infect. 2014;69(2):145–153. doi:10.1016/j.jinf.2014.03.01024637236
  • Tripodi MF, Ragone E, Durante Mangoni E, et al. Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis. 2004;38(10):1394–1400. doi:10.1086/39250315156477
  • Baddour LM, Bayer AS, Fowler VG, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American heart association. Circulation. 2015;132(15):1435–1486. doi:10.1161/CIR.000000000000029626373316
  • Habib G, Antunes MJ, Bongiorni MG, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by European Association for Cardio-Thoracic Surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;21(44):3075–3128.
  • Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control. 1988;16(3):128e40. doi:10.1016/0196-6553(88)90053-32841893
  • Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 20th Informational supplement. CLSI document M100-MS20 [Internet] 2012 Available from: https://clsi.org. Accessed 712, 2020.
  • Danne C, Entenza JM, Mallet A, et al. Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. J Infect Dis. 2011;204(12):1960–1970. doi:10.1093/infdis/jir66622043018
  • Isenring J, Köhler J, Nakata M, et al. Streptococcus gallolyticus subsp. gallolyticus endocarditis isolate interferes with coagulation and activates the contact system. Virulence. 2018;9(1):248–261. doi:10.1080/21505594.2017.139360029072555
  • Jans C, Boleij A. The road to infection: host-microbe interactions defining the pathogenicity of Streptococcus bovis/Streptococcus equinus complex members. Front Microbiol. 2018;10(9):603. doi:10.3389/fmicb.2018.00603
  • Hirota K, Osawa R, Nemoto K, Ono T, Miyake Y. Highly expressed human sialyl Lewis antigen on cell surface of Streptococcus gallolyticus. Lancet. 1996;347:760. doi:10.1016/S0140-6736(96)90109-98602016
  • Vollmer T, Hinse D, Kleesiek K, Dreier J. Interactions between endocarditis-derived Streptococcus gallolyticus subsp. gallolyticus isolates and human endothelial cells. BMC Microbiol. 2010;10:78. doi:10.1186/1471-2180-10-7820233397
  • Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: a critical review and practical guidance. World J Hepatol. 2016;8(6):307–321. doi:10.4254/wjh.v8.i6.30726962397
  • National committee for clinical laboratory standards performance standards for antimicrobial susceptibility testing. Fifteenth information supplement M100-S15. NCCLS [Internet] 2005 Available from: https://clsi.org/. Accessed 712, 2020.
  • Streit JM, Steenbergen JN, Thorne GM, Alder J, Jones RN. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother. 2005;55(4):574–578. doi:10.1093/jac/dki03215722390
  • Dekker JP, Lau AF. An update on the Streptococcus bovis group: classification, identification, and disease associations. J Clin Microbiol. 2016;54(7):1694–1699. doi:10.1128/JCM.02977-1526912760
  • Funke G, Funke-Kissling P. Performance of the new VITEK 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory. J Clin Microbiol. 2005;43(1):84–88. doi:10.1128/JCM.43.1.84-88.200515634954
  • Haanperä M, Jalava J, Huovinen P, Meurman O, Rantakokko-Jalava K. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. J Clin Microbiol. 2007;45(3):762–770. doi:10.1128/JCM.01342-0617215341